Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors
about
Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failureThe expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitorCrystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed InhibitorStructure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors.Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine."Canonical and non-canonical actions of GRK5 in the heart"New paradigms in GPCR drug discovery.Progress towards a public chemogenomic set for protein kinases and a call for contributions.The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.The influence of two functional genetic variants of GRK5 on tau phosphorylation and their association with Alzheimer's disease risk.Potent Pyrimidine and Pyrrolopyrimidine Inhibitors of Testis-Specific Serine/Threonine Kinase 2 (TSSK2).Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.Towards Enzyme-like, Sustainable Catalysis: Switchable, Highly Efficient Asymmetric Synthesis of Enantiopure Biginelli Dihydropyrimidinones or Hexahydropyrimidinones.Impact of paroxetine on proximal β-adrenergic receptor signaling.Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans.
P2860
Q26785936-A4497A95-4FDC-485E-9BD7-C6E8759BED1DQ30250314-815D99A4-392A-43D3-A7F4-AD5514301F28Q35360619-86CCC094-B679-4F20-8F17-CDE978FF86B0Q35978165-D8BD8516-3EB7-4FF4-B98B-D66F3AFAF94EQ35981205-9560EB82-DF32-4420-97B3-218ADF220B7BQ36316194-5828281E-3F14-4731-B698-A15BC2B2CF87Q36679863-0A89E8E6-0237-4551-953B-050D2C276BBBQ37140411-60BC118D-9150-475F-883F-EB379A448D65Q38646648-35779386-485E-4A83-B93D-AF460B72BB4CQ39381430-1AD4511A-7BB3-4D63-B18E-546508C7DC16Q42654068-7B6D6779-1823-4932-A6B8-41DC0A4C68E0Q45068477-EF0C5C7D-9C88-4AC1-8FB4-0AF2538AD3DFQ47603118-84AD2DFC-6501-4463-B7CA-745217E697CDQ48297047-3D9F5FCF-9C40-49AD-AE1A-9896CB2755F3Q50888800-9F2E4E5D-0696-4F7B-BF78-D33ABDE2ED20Q52601019-521D8A48-E6DE-4148-A3F9-5F98BF2B2B65Q54963131-6B792048-0686-4780-AB6A-E540C24B3159
P2860
Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification and structure-f ...... led receptor kinase inhibitors
@ast
Identification and structure-f ...... led receptor kinase inhibitors
@en
Identification and structure-f ...... led receptor kinase inhibitors
@nl
type
label
Identification and structure-f ...... led receptor kinase inhibitors
@ast
Identification and structure-f ...... led receptor kinase inhibitors
@en
Identification and structure-f ...... led receptor kinase inhibitors
@nl
prefLabel
Identification and structure-f ...... led receptor kinase inhibitors
@ast
Identification and structure-f ...... led receptor kinase inhibitors
@en
Identification and structure-f ...... led receptor kinase inhibitors
@nl
P2093
P2860
P50
P356
P1433
P1476
Identification and structure-f ...... led receptor kinase inhibitors
@en
P2093
Kelly M Larimore
Kristoff T Homan
Marta Szklarz
P2860
P304
P356
10.1021/CB5006323
P577
2014-10-03T00:00:00Z